TATA健康发布2025年中期业绩，股东应占溢利2059.6万港元

Core Insights - TATA Health (01255) reported a revenue of HKD 42.118 million for the six months ending June 30, 2025, representing a year-on-year decline of 41.8% [1] - The company achieved a profit attributable to shareholders of HKD 20.596 million, compared to a loss of HKD 5.13 million in the same period last year [1] - Basic earnings per share were HKD 0.08 [1] Revenue Analysis - The decline in revenue was primarily attributed to a decrease in footwear business income [1] - The challenging environment for retail in Hong Kong was influenced by weak consumer sentiment and ongoing economic uncertainty [1]